Article Name Global/International
Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany.
04th September, 2025
Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management.
01st September, 2025
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.
13th August, 2025
Authority to Operate (ATO) certification from the U.S. Department of Defense affirms Dräger’s leadership in safeguarding patient data, delivering a fully ATO-certified anesthesia portfolio trusted by hospitals worldwide.
12th August, 2025
BD’s Urology and Critical Care and Surgery units achieve top-tier recognition from the Healthcare Industry Resilience Collaborative, affirming its leadership in supply chain transparency, risk mitigation, and operational excellence
06th August, 2025
The expansion at its Nebraska facility will boost syringe output by hundreds of millions annually, enhancing supply resilience and supporting safe, high-quality patient care across U.S. hospitals.
05th August, 2025
In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead.
04th August, 2025
With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.
04th August, 2025
Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies.
31st July, 2025
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.
31st July, 2025
Milestone underscores ClariMed’s commitment to quality excellence and reinforces its position as a trusted partner in navigating complex global regulatory landscapes
30th July, 2025
Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease
30th July, 2025
Strategic relocation from Hong Kong strengthens ties to Asia’s thriving MedTech ecosystem, enhances collaboration with global partners, and supports ambitious expansion plans
30th July, 2025
AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes
30th July, 2025
Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types
30th July, 2025
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance
30th July, 2025
First camera-agnostic motion tracking solution for laparoscopic surgery delivers real-time insight into surgical technique and proficiency across all devices and operating rooms
30th July, 2025
First and only purpose-built solution delivering rapid and complete luminal clot removal in small vessel and arteriovenous access cases
30th July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer